B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioPlus Co Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Long-Term Investments
â‚©8B
CAGR 3-Years
122%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Long-Term Investments
â‚©302.6B
CAGR 3-Years
235%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
HLB Inc
KOSDAQ:028300
Long-Term Investments
â‚©306.7B
CAGR 3-Years
19%
CAGR 5-Years
27%
CAGR 10-Years
54%
T
T&L Co Ltd
KOSDAQ:340570
Long-Term Investments
â‚©4.1B
CAGR 3-Years
1 173%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Long-Term Investments
â‚©29.7B
CAGR 3-Years
N/A
CAGR 5-Years
215%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Long-Term Investments
â‚©10.6B
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
26%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

What is BioPlus Co Ltd's Long-Term Investments?
Long-Term Investments
8B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Long-Term Investments amounts to 8B KRW.

What is BioPlus Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
122%

Over the last year, the Long-Term Investments growth was 21%. The average annual Long-Term Investments growth rates for BioPlus Co Ltd have been 122% over the past three years .

Back to Top